Verum Messenger: Innovation, AI, and Absolute Security -- A New Level of Communication

Udgivet den 04-10-2024  |  kl. 08:51  |  

LONDON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Verum Messenger has unveiled a global update that takes the platform to an entirely new level in the realm of communications. Now, the messenger not only offers standard features for chatting but also introduces advanced technologies such as integration with the neural network Verum AI, built-in eSIM, and complete blocking of screenshots and screen recording. This update makes Verum Messenger one of the most high-tech and secure messengers on the market today.

Integration with Verum AI: A Smart Assistant Always at Hand

The main innovation of the update is the integration with Verum AI -- an intelligent system designed to make interaction with the messenger even more convenient and functional. Verum AI is a generative AI that can respond to user queries, search for necessary information, translate text, generate content, and analyze data.

Built-in eSIM: Global Internet in Your Phone

Another unique feature of Verum Messenger is the built-in eSIM, which allows you to connect to mobile internet without a physical SIM card or roaming charges. For those who frequently travel or work in different countries, this means always staying connected without the need to switch operators or search for Wi-Fi hotspots.

Security at a New Level

Verum Messenger's commitment to privacy and security principles is reinforced by the implementation of complete blocking of screenshots and screen recording within the app, eliminating the risk of confidential information leakage. Users can be confident that their messages will remain solely on their devices and won't be inadvertently captured by third parties.

Distinctive Features of Verum Messenger

Verum Messenger offers users a range of unique features that set it apart from other messengers:

Recovery Key: If you change devices or log out of your account, you can restore all chats using your personal recovery key.Group Chats and Channels: Create groups and channels with the ability to add up to 10,000 participants, making the messenger an ideal tool for managing communities and businesses.Built-in VPN: Connecting through a VPN hides your IP address, encrypts traffic, and protects against tracking, making communication secure even in the most unsafe network conditions.User Privacy Settings: Control your profile visibility and manage who can message you, providing maximum flexibility in security settings.

Download Verum Messenger from the App Store: https://apps.apple.com/app/id1550499454

Media contact: info@verum.im

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7f116e5d-f867-4c34-b53d-f425e8bfb83e


\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed